Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)

NCT01019486 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Type 1 Diabetes Mellitus

Interventions

DRUG: Regadenoson myocardial perfusion imaging
DRUG: Regadenoson MRI myocardial blood flow

Sponsor

University of Colorado, Denver